Vanguard Personalized Indexing Management, LLC
Position in ESPR — Esperion Therapeutics, Inc.
CIK 1767306
OAKLAND, CA
Position in ESPR
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$0
+$0 QoQ
Shares Held
13,236
+8.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Vanguard Personalized Indexing Management, LLC holds $33,072,704 across 32 Drug Manufacturers - Specialty & Generic names. ESPR ranks #32 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
|
333,247 | $4,828,749 | |
| 2 | VTRS |
Viatris Inc
|
284,926 | $4,524,624 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
7,747 | $4,197,557 | |
| 4 | ZTS |
Zoetis Inc.
|
53,516 | $3,845,659 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
127,525 | $2,044,225 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
11,004 | $1,854,614 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
74,835 | $1,841,689 | |
| 8 | HLN |
Haleon plc
|
174,951 | $1,632,292 |
All Filings in ESPR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 13,236 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | — | 12,181 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | — | 11,412 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | — | 11,089 | Shares | Sole | 2025-10-31 | |
| No filing history on record for this holder in this stock. | ||||||